Fady Ibraham Malik - Mar 10, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Fady Malik
Stock symbol
RCKT
Transactions as of
Mar 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 06:14 PM
Previous filing
Mar 8, 2022
Next filing
Apr 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +33.2K $0.00 33.2K Mar 10, 2022 Common Stock 33.2K $16.65 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +8.64K $0.00 8.64K Mar 10, 2022 Common Stock 8.64K $16.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 33,199 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on March 10, 2025.
F2 This option represents a right to purchase a total of 8,641 shares of the Issuer's common stock, which will fully vest on March 10, 2024.